Exonate rebrands as Foventa Therapeutics to advance diabetic eye drop therapy
Exonate Limited has changed its name to Foventa Therapeutics and shifted its focus to clinical development for non-proliferative diabetic retinopathy. The new name is inspired by the fovea, and the company describes its motto as Simply Sharper. According to the company, Foventa is advancing FOV407,
<p>Exonate Limited has changed its name to Foventa Therapeutics and shifted its focus to clinical development for non-proliferative diabetic retinopathy. The new name is inspired by the fovea, and the company describes its motto as Simply Sharper. According to the company, Foventa is advancing FOV407, </p>